phrykt

Health In Tech, Inc. (HIT): who owns it and who trades it

As of Nov 16, 2026, HIT insiders reported 6 open-market sales worth $40.6K and no purchases in the last 12 months, with 34% of the sale value made under pre-set 10b5-1 plans. The largest seller was Timothy Hayes (Director), with $26.9K. 1 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Health In Tech

From the latest filings

Overall: more selling than buying. Insiders and famous investors mostly sold.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, HIT insiders reported $0 of open-market purchases and $40.6K of sales. 34% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$40.6K
6 trades, 2 people
Sales under a 10b5-1 plan
34%
Share of sale value
Latest trade
Nov 3, 2026
Filed Nov 5, 2026

Purchases and sales by month

$37.7K$37.7KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 3, 2026Zain Syed HasanChief Growth OfficerSale plan1,667$0.55$917Form 4
Oct 16, 2026Zain Syed HasanChief Growth OfficerSale plan3,333$0.62$2.1KForm 4
Sep 14, 2026Timothy HayesDirectorSale12,000$0.89$10.7KForm 4
Sep 11, 2026Zain Syed HasanChief Growth OfficerSale plan11,667$0.92$10.7KForm 4
Sep 11, 2026Timothy HayesDirectorSale12,000$0.91$10.9KForm 4
Sep 9, 2026Timothy HayesDirectorSale5,730$0.93$5.3KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Timothy HayesDirector–$26.9KSep 14, 2026
Zain Syed HasanChief Growth Officer–$13.7KNov 3, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

HIT short interest

602,449 HIT shares are sold short. Over the last 12 reports the number of shares short went up 8%.

As of Oct 30, 2026, 602,449 HIT shares were sold short, up 42.3% from the report before. At the average daily volume of 58,254 shares, buying them all back would take about 10.3 trading days (days to cover).

Shares short

602,449May 15Oct 301.16M

Days to cover

10.3May 15Oct 3014.6

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026602,449–+42%58,25410.3
Oct 15, 2026423,257–+4%161,6692.6
Sep 30, 2026408,599–-33%603,6441.0
Sep 15, 2026614,153–+40%58,19210.6
Aug 31, 2026439,926–-12%64,8616.8
Aug 14, 2026497,437–-30%77,5946.4
Jul 31, 2026713,957–-0%55,61112.8
Jul 15, 2026717,385–+27%62,62011.5
Jun 30, 2026565,388–-47%122,4124.6
Jun 15, 20261.07M–+57%221,9094.8
May 29, 2026679,762–+21%402,8631.7
May 15, 2026560,340–-36%200,2342.8

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Health In Tech company events

Health In Tech filed 17 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership, listing). The latest was on Nov 6, 2026.

  1. Nov 6, 2026AgreementAs previously disclosed, on August 12, 2026, Health In Tech, Inc. entered into a Standby Equity Purchase Agreement and a related Registration Rights Agreement. Filing
  2. Oct 26, 2026LeadershipThe Board of Directors of Health In Tech, Inc. appointed Sanjay Shrestha to serve as the Chief Executive Officer of the Company, effective as of such date. Filing
  3. Oct 16, 2026ListingHealth In Tech, Inc. received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that, as a result of the resignation of Sanjay Shrestha from the Board of Directors of the Company and the Audit Committee of the Board on August 10, 2026, as was… Filing
  4. Sep 30, 2026AnnouncementShared information with investors. Filing
  5. Aug 13, 2026AnnouncementShared information with investors. Filing
  6. Aug 13, 2026AnnouncementShared information with investors. Filing
  7. Aug 13, 2026ResultsReleased financial results. Filing
  8. May 14, 2026AnnouncementShared information with investors. Filing
  9. May 13, 2026AnnouncementShared information with investors. Filing
  10. May 13, 2026ResultsReleased financial results. Filing
  11. May 1, 2026LeadershipFollowing receipt of formal notice on April 27, 2026, Dustin Plantholt departed from his role as Chief AI & Marketing Officer of Health In Tech, Inc., effective as of April 30, 2026, as part of a business transition and not as a result of any disagreement with the Company on any matter relating to… Filing
  12. Mar 27, 2026AnnouncementShared information with investors. Filing
  13. Mar 27, 2026AgreementHealth In Tech, Inc., a Nevada corporation, issued a press release announcing the closing of its previously announced private investment in public equity financing, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference herein. Filing
  14. Mar 26, 2026AgreementHealth In Tech, Inc., a Nevada corporation, announced that it has entered into a securities purchase agreement with certain accredited investors (each, a “Purchaser” and collectively, the “Purchasers”) relating to a private investment in public equity financing for an aggregate of 5,600,000 shares… Filing
  15. Mar 25, 2026ResultsReleased financial results. Filing
  16. Dec 2, 2025AgreementHealth In Tech, Inc., a Nevada corporation, entered into lock-up agreements (each, a “Lock-Up Agreement”) with certain members of its executive management team, vice presidents across functions and Board of Directors pursuant to which each Lock-Up Holder has voluntarily agreed, among other things… Filing
  17. Nov 26, 2025LeadershipImran Yousuf, the Chief Technology Officer of Health in Tech, Inc., was terminated from his position as Chief Technology Officer, without cause. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Health In Tech financials

Famous investors that hold HIT

1 of the 50 well-known investors we track reported holding HIT in their latest 13F filing. The largest position is Ken Griffin's, worth $131K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026159,161$131K0.0%-10%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Health In Tech, Inc. (HIT) stock

Are HIT insiders buying or selling?

In the last 12 months, HIT insiders reported no open-market purchases and 6 sales worth $40.6K. The latest trade was on Nov 3, 2026. See every trade.

What is the short interest in HIT?

As of Oct 30, 2026, 602,449 HIT shares were sold short, up 42.3% from the report before. At the average daily volume of 58,254 shares, buying them all back would take about 10.3 trading days (days to cover). See the history.

Which famous investors hold HIT?

1 of the 50 well-known investors we track reported HIT in their latest 13F filing, including Ken Griffin. The largest position is worth $131K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.